Ticker: TSX - TOS
Shares Outstanding: 58,809,682
QUEBEC CITY, April 25, 2012 /CNW Telbec/ - TSO3 Inc. (TSX: TOS) ("TSO3" or the "Corporation") an innovator in sterilization technology for medical devices in healthcare settings, is pleased to announce it will hold its Annual and Special Meeting of Shareholders today in Québec City.
| EVENT: | TSO3 2011 ANNUAL MEETING OF SHAREHOLDERS |
| DATE: | WEDNESDAY APRIL 25, 2012 |
| TIME: | 10:30 EST |
| LOCATION: |
PALAIS MONTCALM - Salle d'Youville 995 Place d'Youville, Québec (QC), G1R 3P1 |
| REFERENCE: | CNW GROUP |
| LENGTH: | APPROXIMATELY 1 HOUR 30 MINUTES |
To listen to the live webcast of the event, please click on the link below. The webcast will be archived for a 90-day period.
Webcast: http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=3815680
About TSO3
TSO3, founded in Québec City in 1998, specializes in the research and development of innovative, high-performance medical instrument sterilization technology with high commercial potential. TSO3 designs products for sterile processing areas in the hospital environment and offers an advantageous replacement solutions to other low temperature sterilization processes currently used in hospitals.
For more information about TSO3, visit the Company's Web site at www.tso3.com
The statements in this release and oral statements made by representatives of TSO3 relating to matters that are not historical facts (including, without limitation, those regarding the timing or outcome of any financing undertaken by TSO3) are forward-looking statements that involve certain risks, uncertainties and hypotheses, including, but not limited to, general business and economic conditions, the condition of the financial markets, the ability of TSO3 to obtain financing on favourable terms and other risks and uncertainties.
The TSX has neither approved nor disapproved the information contained herein and accepts no responsibility for it.
Source: TSO3 Inc.
Information:
Caroline Côté
Director - Investor and Business Relations
(418) 651-0003, Ext. 237
Email: [email protected]
Share this article